Stage 3 melanoma attacked with immunotherapy and a virus-like particleNovember 28, 2022MelanomaOncology
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerColon and RectalHead & Neck/Thyroid CancersMelanomaGenitourinary Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerOncologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
‘Smoking gun–level’ evidence found linking air pollution with lung cancerSeptember 14, 2022Lung CancerOncologyMelanoma
